Physician
Richmond Multi-Specialty, LLC
Richmond Multi-Specialty, LLC was paid $3.89M by Medicaid between Oct 2019 and Dec 2024, across 78 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.
33Billing provider infoRICHMOND MULTI-SPECIALTY, LLC
FREDERICKSBURG, VA 22401
FREDERICKSBURG, VA 22401
33aNPI1922336304assigned 11/24/2009
33bProvider typePlastic Surgery Physician
28Total paid$3.89M
24GClaims93,469
24DCodes billed78
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Plastic Surgery Physician providers in Virginia
Rank by total paid#1 of 10
Median peer was paid$3K
This provider vs. median1,507×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official JOSEPH, LOUIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 6,537 | $145K | |
| 2020 | 17,878 | $787K | |
| 2021 | 16,118 | $743K | |
| 2022 | 18,374 | $766K | |
| 2023 | 18,860 | $787K | |
| 2024incomplete | 15,702 | $664K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 23,131 | 19,359 | $1.51M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 18,188 | 15,969 | $966K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.2% | 3,353 | 3,071 | $240K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.6% | 2,263 | 2,108 | $220K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.7% | 2,906 | 2,452 | $183K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.8% | 1,960 | 1,883 | $147K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.8% | 1,633 | 1,513 | $108K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.6% | 1,443 | 1,300 | $101K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.9% | 910 | 864 | $73K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 3,664 | 3,152 | $43K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 322 | 283 | $36K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 344 | 330 | $27K |
66 more codes
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 314 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,355 | $21K |
| 92551 | <1% | 1,674 | $15K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 474 | $14K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,565 | $13K |
| 90670 | <1% | 1,660 | $12K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 81 | $12K |
| 99173 | <1% | 5,142 | $11K | |
| 20610 | <1% | 273 | $11K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 88 | $11K |
| 90677 | <1% | 354 | $10K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,057 | $8K |
| 96127 | <1% | 1,640 | $8K | |
| 90686 | <1% | 2,677 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 483 | $5K |
| 73562 | <1% | 167 | $5K | |
| 90651 | <1% | 280 | $3K | |
| 90671 | <1% | 146 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 88 | $3K |
| 90710 | <1% | 293 | $3K | |
| 90697 | <1% | 285 | $3K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 227 | $2K |
| 90723 | <1% | 384 | $2K | |
| 90698 | <1% | 533 | $2K | |
| 90648 | <1% | 589 | $2K | |
| 99174 | <1% | 457 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,662 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 610 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 38 | $2K |
| 90734 | <1% | 167 | $2K | |
| 90381 | <1% | 27 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,210 | $2K |
| 90633 | <1% | 429 | $2K | |
| 99385 | <1% | 15 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 13 | $1K |
| 90681 | <1% | 179 | $1K | |
| 54150 | <1% | 15 | $1K | |
| 99381 | <1% | 13 | $994.94 | |
| 90680 | <1% | 258 | $926.79 | |
| 81025 | <1% | 112 | $647.13 | |
| 90715 | <1% | 68 | $545.03 | |
| 99443 | <1% | 24 | $457.15 | |
| 73564 | <1% | 12 | $398.64 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 13 | $376.18 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 13 | $376.06 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 15 | $351.33 |
| 80050 | General health panel | <1% | 21 | $333.20 |
| 80061 | Lipid panel | <1% | 69 | $316.91 |
| 99441 | <1% | 14 | $286.18 | |
| 90744 | <1% | 118 | $284.76 | |
| 90656 | <1% | 189 | $260.24 | |
| 80053 | Comprehensive metabolic panel | <1% | 104 | $249.44 |
| 87276 | <1% | 118 | $214.26 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 24 | $205.53 |
| 87275 | <1% | 118 | $189.39 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 31 | $177.06 |
| 81001 | <1% | 84 | $171.33 | |
| 87807 | <1% | 12 | $159.84 | |
| 93000 | <1% | 12 | $130.43 | |
| 84439 | <1% | 20 | $126.73 | |
| 81003 | <1% | 60 | $107.51 | |
| 90696 | <1% | 17 | $78.18 | |
| 90661 | <1% | 17 | $33.05 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 22 | $28.00 |
| 90474 | <1% | 31 | $16.23 | |
| 99024 | 0% | 92 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOSEPH, LOUIS (VP)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.